Skip to main content

Table 1 Patient demographics and tumor characteristics

From: Assessment of preoperative axillary nodal disease burden: breast MRI in locally advanced breast cancer before, during and after neoadjuvant endocrine therapy

Characteristic

Value

No. of patients

33

Age (y)

  Meana

74.4 ± 6.7

  Range

58- 84

Lymphadenopathy at US

  Negative

4

  Positive

29

Clinical T stage

  T2

2 (6.1)

  T3

11 (33.3)

  T4

20 (60.6)

Clinical N stage

  N0

14 (42.4)

  N1

16 (48.5)

  N2

2 (6.1)

  N3

1 (3.0)

Clinical stage

  IIB

4 (12.12)

  IIIA

7 (21.21)

  IIIB

20 (60.61)

  IIIC

1 (3.03)

  IV

1 (3.03)

Histologic type

  Ductal

26 (78.8)

  Lobular

5 (15.2)

  Other

2 (6.1)

Histologic grade

  1

1 (3.0)

  2

26 (78.8)

  3

5 (15.2)

  missing

1 (3.0)

Breast Surgery

  Breast-conserving surgery

4 (87.9)

  Total mastectomy

29 (12.1)

Lymph node surgery

  SLNB

7 (21.21)

  ALND

18 (54.55)

  Both

8 (24.24)

ypT stage

  Tis

1 (3.0)

  T1

8 (24.2)

  T2

19 (57.6)

  T3

3 (9.1)

  T4

2 (6.1)

ypN stage

  N0

6 (18.2)

  N1

17 (51.5)

  N2

9 (27.3)

  N3

1 (3.0)

  1. Unless specified otherwise, data are number of cases, with percentages in parentheses
  2. ALND Axillary Lymph Node Dissection, SLNB Sentinel Lymph Node Biopsy, US Ultrasound
  3. a Data are means ± standard deviations